Position in NVS
as of Jun 30, 2026
· filed Jul 16, 2026
Position Value
$4,871,171
-$91,982 QoQ
Shares Held
31,082
-4.3% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.06%
of 13F equity value
Holder Rank
#266
of 1,603 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in NVS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Crossmark Global Holdings, Inc. holds $252,849,441 across 15 Drug Manufacturers - General names. NVS ranks #8 (1.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | GILD |
Gilead Sciences, Inc.
|
541,294 | $68,387,083 | |
| 2 | LLY |
ELI LILLY & Co
|
44,150 | $52,954,838 | |
| 3 | MRK |
Merck & Co., Inc.
|
264,831 | $34,030,783 | |
| 4 | ABBV |
AbbVie Inc.
|
129,445 | $32,573,539 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
365,001 | $21,031,357 | |
| 6 | AMGN |
Amgen Inc
|
40,262 | $14,579,675 | |
| 7 | JNJ |
Johnson & Johnson
|
34,792 | $8,836,124 | |
| 8 | NVS |
Novartis AG
This page
|
31,082 | $4,871,171 |
All Filings in NVS
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,871,171 | 31,082 | Shares | Sole | 2026-07-16 | |
| 2026-03-31 | $4,963,153 | 32,492 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $4,892,041 | 35,483 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $4,753,856 | 37,070 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $4,521,296 | 37,363 | Shares | Sole | 2025-08-08 | |
| 2025-03-31 | $4,310,820 | 38,669 | Shares | Sole | 2025-04-30 | |
| 2024-12-31 | $3,719,868 | 38,227 | Shares | Sole | 2025-01-16 | |
| 2024-09-30 | $4,096,666 | 35,617 | Shares | Sole | 2024-11-04 | |
| 2024-06-30 | $2,958,842 | 27,793 | Shares | Sole | 2024-07-29 | |
| 2024-03-31 | $2,654,658 | 27,444 | Shares | Sole | 2024-05-13 | |
| 2023-12-31 | $2,809,187 | 27,822 | Shares | Sole | 2024-02-13 | |
| 2023-09-30 | $2,793,408 | 27,424 | Shares | Sole | 2023-11-08 | |
| 2023-06-30 | $3,156,969 | 31,285 | Shares | Sole | 2023-07-31 | |
| 2023-03-31 | $2,767,176 | 30,078 | Shares | Sole | 2023-05-12 | |
| 2022-12-31 | $2,686,400 | 29,612 | Shares | Sole | 2023-01-19 | |
| 2022-09-30 | $2,259,245 | 29,723 | Shares | Sole | 2022-11-01 | |
| 2022-06-30 | $2,154,669 | 25,490 | Shares | Sole | 2022-07-29 | |
| 2022-03-31 | $2,345,557 | 26,730 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $2,190,248 | 25,040 | Shares | Sole | 2022-01-10 | |
| 2021-09-30 | $2,045,317 | 25,010 | Shares | Sole | 2021-10-21 | |
| 2021-06-30 | $4,911,449 | 53,830 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $5,699,806 | 66,680 | Shares | Sole | 2021-04-15 | |
| 2020-12-31 | $7,496,419 | 79,386 | Shares | Sole | 2021-01-14 | |
| 2020-09-30 | $6,850,882 | 78,782 | Shares | Sole | 2020-10-08 | |
| 2020-06-30 | $5,521,809 | 63,222 | Shares | Sole | 2020-08-14 | |
| 2020-03-31 | $7,764,728 | 94,175 | Shares | Sole | 2020-04-28 | |
| No filing history on record for this holder in this stock. | ||||||